MicroRNA-21 promotes pancreatic β cell function through modulating glucose uptake.

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Diseases

Background:

• Pancreatic beta cell dysfunction is central to type 2 diabetes pathogenesis.
• MicroRNA-21 (miR-21) is upregulated in glucose intolerance and type 2 diabetes.
• The precise role of miR-21 in regulating beta cell function is not well understood.

Purpose of the Study:

• To elucidate the role of miR-21 in regulating glucose-stimulated insulin secretion (GSIS).
• To identify the molecular pathway through which miR-21 influences beta cell function.
• To evaluate the therapeutic potential of miR-21 in type 2 diabetes models.

Main Methods:

• Generation and analysis of mice lacking miR-21 specifically in beta cells (miR-21βKO).
• Assessment of glucose tolerance and insulin secretion in miR-21βKO mice.
• Investigation of the miR-21-Pdcd4-AP-1 pathway and Glut2 expression.
• In vivo studies involving pancreatic delivery of miR-21 in type 2 diabetic mice.

Main Results:

• miR-21βKO mice exhibit glucose intolerance due to impaired GSIS.
• miR-21 promotes glucose uptake and insulin secretion by upregulating Glut2 expression via a miR-21-Pdcd4-AP-1 pathway.
• Overexpression of Glut2 rescues the impaired GSIS in knockout islets.
• Pancreatic miR-21 delivery in db/db mice reduces blood glucose levels.

Conclusions:

• miR-21 in pancreatic beta cells is essential for normal GSIS.
• The miR-21-Pdcd4-AP-1-Glut2 axis is a key regulator of beta cell function.
• miR-21 represents a promising therapeutic target for managing type 2 diabetes.